论文信息 - MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study - 字舞流文

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study

F. Bertucci | D. Birnbaum | P. Finetti | O. Chinot | M. Campone | T. Petit | S. V. van Laere | N. Ueno | J. Pierga | J. Borg | P. Viens | E. Tabouret | T. Bachelot | J. Gligorov | J. Ferrero | A. Gonçalves | F. Lerebours | C. Lévy | H. Roché | Y. Toiron